Residual dyslipidaemia after statin treatment in France: Prevalence and risk distribution
- 1 May 2010
- journal article
- Published by Elsevier BV in Archives of Cardiovascular Diseases
- Vol. 103 (5), 302-309
- https://doi.org/10.1016/j.acvd.2010.04.003
Abstract
No abstract availableFunding Information
- Merck
This publication has 28 references indexed in Scilit:
- Meta-analysis of Comparative Efficacy of Increasing Dose of Atorvastatin Versus Rosuvastatin Versus Simvastatin on Lowering Levels of Atherogenic Lipids (from VOYAGER)The American Journal of Cardiology, 2010
- Assessment of lipid-lowering treatment in France – The CEPHEUS studyArchives of Cardiovascular Diseases, 2008
- The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patientsDiabetes and Vascular Disease Research, 2008
- Triglycerides and the Risk of Coronary Heart Disease: 10 158 Incident Cases Among 262 255 Participants in 29 Western Prospective StudiesYearbook of Pathology and Laboratory Medicine, 2008
- Intervention studies on Mediterranean diet and cardiovascular riskMolecular Nutrition & Food Research, 2007
- Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000New England Journal of Medicine, 2007
- Explaining the Decline in Coronary Heart Disease Mortality in Finland between 1982 and 1997American Journal of Epidemiology, 2005
- The triglyceride–high-density lipoprotein axis: An important target of therapy?American Heart Journal, 2004
- Alcohol intake and diet in France, the prominent role of lifestyleEuropean Heart Journal, 2004
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998